Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
5
×
Tags
clinical trials
5
×
fda
5
×
life sciences
national blog main
san diego blog main
san diego top stories
biotech
boston blog main
boston top stories
national top stories
new york blog main
new york top stories
san francisco blog main
san francisco top stories
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
indiana blog main
indiana top stories
raleigh-durham blog main
raleigh-durham top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
cancer
drugs
merck
national
regeneron pharmaceuticals
rna interference
roche
a2 biotherapeutics
aduro biotech
agency
aimmune therapeutics
akcea therapeutics
What
time
5
×
fda
approved
drug
friday
medicine
patients
add
agency
ago
aimmune
allergy
alliance
alnylam
approval
approve
awaits
awarded
bio
biological
bristol
buy
called
calls
cancer
carbidopa
changing
color
combination
control
crispr
crossed
daily
days
decades
decision
deeper
developed
discovered
disease
Language
unset
Current search:
photo
×
" clinical trials "
×
fda
×
time
×
@xconomy.com
3 years ago
Bio Roundup: CRISPR Kudos, Bristol Myers’s Buy, RNAi Alliance & More
@xconomy.com
4 years ago
Neurocrine Gets FDA Nod for Once-Daily “Add-On” Parkinson’s Pill
@xconomy.com
4 years ago
Aimmune Awarded First FDA Approval for a Peanut Allergy Therapy
@xconomy.com
5 years ago
Genetic Medicine: FDA OKs 2nd Cancer Drug that Targets DNA, not Tissues
@xconomy.com
5 years ago
Patients Have “Fingers Crossed” As Alnylam Awaits Historic FDA Decision